G T250 (Ticlopidine hydrochloride 250 mg)

Pill imprint G T250 has been identified as Ticlopidine hydrochloride 250 mg.

Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G T250

Ticlopidine hydrochloride 250 mg G T250
Ticlopidine hydrochloride
Imprint:
G
T250
Strength:
250 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0599

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)